Oct 31, 2024, 17:27
Uncovering how pancreatic cancer cells evade the immune system – Cancer Research Institute
“CRI Postdoctoral Fellow Dr. Falcomatà at Icahn School of Medicine at Mount Sinai is leading cutting-edge research aimed at uncovering how pancreatic cancer cells evade the immune system.
Discover how your support is fueling her impact in accelerating lifesaving cancer immunotherapy research.”
Proceed to the video attached to the post.
Chiara Falcomatà, PhD, is a Postdoctoral Fellow at the Icahn School of Medicine at Mount Sinai, focusing on research across various cancers, with a particular emphasis on pancreatic cancer. Previously, she spent over five years as a Postdoctoral Research Fellow at the Technical University of Munich.
More posts featuring Cancer Research Institute.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 15:29
Nov 13, 2024, 15:25
Nov 13, 2024, 14:55
Nov 13, 2024, 14:47
Nov 13, 2024, 14:43
Nov 13, 2024, 14:37
Nov 13, 2024, 14:05
Nov 13, 2024, 12:13